105.80
price up icon0.17%   0.18
after-market アフターアワーズ: 104.65 -1.15 -1.09%
loading

Revvity Inc (RVTY) 最新ニュース

pulisher
07:19 AM

Is Revvity Stock Underperforming the Nasdaq? - MSN

07:19 AM
pulisher
Mar 28, 2025

High Content Screening/Imaging Technology Analysis and Global Market Forecasts 2025-2029 with Danaher, Revvity, Thermo Fischer Scientific, Agilent Technologies and Yokogawa LeadingResearchAndMarkets.com - Bluefield Daily Telegraph

Mar 28, 2025
pulisher
Mar 28, 2025

Is Revvity Stock Underperforming The Nasdaq? - Barchart

Mar 28, 2025
pulisher
Mar 27, 2025

Is Revvity Gaining or Losing Market Support? - Benzinga

Mar 27, 2025
pulisher
Mar 27, 2025

Revvity Expands Alliance With Genomics England To Drive Research Into Newborn Genomic Sequencing in England - Technology Networks

Mar 27, 2025
pulisher
Mar 25, 2025

Revvity Stock Tumbles Despite Expanding Genomics England Alliance - MSN

Mar 25, 2025
pulisher
Mar 25, 2025

The total return for Revvity (NYSE:RVTY) investors has risen faster than earnings growth over the last five years - Yahoo Finance

Mar 25, 2025
pulisher
Mar 21, 2025

Revvity Expands Alliance with Genomics England to Drive Research into Newborn Genomic Sequencing in England - BioSpace

Mar 21, 2025
pulisher
Mar 20, 2025

Revvity Expands Alliance with Genomics England -March 20, 2025 at 02:10 pm EDT - Marketscreener.com

Mar 20, 2025
pulisher
Mar 20, 2025

Massive Breakthrough: Revvity's 100K Newborn Genetic Screening Program Targets 200 Rare Diseases - StockTitan

Mar 20, 2025
pulisher
Mar 20, 2025

May 16th Options Now Available For Revvity (RVTY) - Nasdaq

Mar 20, 2025
pulisher
Mar 20, 2025

Should You Think About Buying Revvity, Inc. (NYSE:RVTY) Now? - Simply Wall St

Mar 20, 2025
pulisher
Mar 19, 2025

Revvity Inc. stock underperforms Wednesday when compared to competitors - MarketWatch

Mar 19, 2025
pulisher
Mar 19, 2025

Revvity's AI-Powered Cellular Imaging & Research Antibodies - openPR

Mar 19, 2025
pulisher
Mar 17, 2025

KeyBanc Adjusts Price Target on Revvity to $145 From $135, Maintains Overweight Rating - MarketScreener

Mar 17, 2025
pulisher
Mar 12, 2025

Learn to Evaluate (RVTY) using the Charts - Stock Traders Daily

Mar 12, 2025
pulisher
Mar 11, 2025

Revvity at Leerink Global Healthcare Conference: Strategic Resilience Amid Challenges - Investing.com

Mar 11, 2025
pulisher
Mar 11, 2025

Jones Financial Companies Lllp Acquires 1,228 Shares of Revvity, Inc. (NYSE:RVTY) - Defense World

Mar 11, 2025
pulisher
Mar 09, 2025

Mutual of America Capital Management LLC Cuts Stock Position in Revvity, Inc. (NYSE:RVTY) - Defense World

Mar 09, 2025
pulisher
Mar 07, 2025

PerkinElmer Stock Price | RVTY Stock Quote, News, and History - Markets Insider

Mar 07, 2025
pulisher
Mar 06, 2025

Sanctuary Advisors LLC Purchases Shares of 1,872 Revvity, Inc. (NYSE:RVTY) - Defense World

Mar 06, 2025
pulisher
Mar 06, 2025

Revvity’s EUROIMMUN Receives CE Mark for Novel Measles Antibody Detection Assay - Technology Networks

Mar 06, 2025
pulisher
Mar 06, 2025

Revvity, Inc. (NYSE:RVTY) Receives Consensus Recommendation of “Moderate Buy” from Brokerages - Defense World

Mar 06, 2025
pulisher
Mar 05, 2025

Revvity Expands Measles Testing Accessibility with EUROIMMUN Anti-Measles Virus ELISA 2.0 - Lab Manager Magazine

Mar 05, 2025
pulisher
Mar 05, 2025

Revvity's (NYSE:RVTY) Solid Earnings Have Been Accounted For Conservatively - Yahoo Finance

Mar 05, 2025
pulisher
Mar 04, 2025

What Does the Market Think About Revvity? - Benzinga

Mar 04, 2025
pulisher
Mar 04, 2025

Private Advisor Group LLC Grows Stock Holdings in Revvity, Inc. (NYSE:RVTY) - Defense World

Mar 04, 2025
pulisher
Mar 03, 2025

Revvity Says Euroimmun Gets CE Mark for Measles Antibody Detection -March 03, 2025 at 10:28 am EST - Marketscreener.com

Mar 03, 2025
pulisher
Mar 03, 2025

High-Throughput Screening Technology Analysis and Global - GlobeNewswire

Mar 03, 2025
pulisher
Mar 03, 2025

High-Throughput Screening Technology Analysis and Global Markets 2021-2024 & 2025-2029 with Danaher, Thermo Fisher Scientific., Charles River Laboratories, Revvity and Bio-Rad Laboratories Leading - Yahoo Finance

Mar 03, 2025
pulisher
Mar 03, 2025

Winners And Losers Of Q4: Revvity (NYSE:RVTY) Vs The Rest Of The Research Tools & Consumables Stocks - Yahoo Finance

Mar 03, 2025
pulisher
Mar 03, 2025

Jefferies raises Revvity stock price target to $130, maintains Hold - MSN

Mar 03, 2025
pulisher
Mar 01, 2025

Is Revvity, Inc.'s (NYSE:RVTY) Stock Price Struggling As A Result Of Its Mixed Financials? - Simply Wall St

Mar 01, 2025
pulisher
Feb 28, 2025

3 Reasons to Sell RVTY and 1 Stock to Buy Instead - Yahoo Finance

Feb 28, 2025
pulisher
Feb 27, 2025

Principal Financial Group Inc. Sells 4,253 Shares of Revvity, Inc. (NYSE:RVTY) - Defense World

Feb 27, 2025
pulisher
Feb 27, 2025

New York State Common Retirement Fund Reduces Stock Position in Revvity, Inc. (NYSE:RVTY) - Defense World

Feb 27, 2025
pulisher
Feb 27, 2025

Do Options Traders Know Something About Revvity (RVTY) Stock We Don't? - MSN

Feb 27, 2025
pulisher
Feb 25, 2025

Revvity Predicts Lower 2025 Earnings Despite Strong Fourth Quarter - Finimize

Feb 25, 2025
pulisher
Feb 24, 2025

Revvity: Acquisitions In High-Growth Sectors, Excellent Debt Levels Create Notable Growth Potential - Seeking Alpha

Feb 24, 2025
pulisher
Feb 22, 2025

Revvity, Inc. (NYSE:RVTY) Shares Acquired by Vontobel Holding Ltd. - Defense World

Feb 22, 2025
pulisher
Feb 21, 2025

Are Wall Street Analysts Bullish on Revvity Stock? - MSN

Feb 21, 2025
pulisher
Feb 21, 2025

Revvity ignites scientific breakthroughs at SLAS2025 - MSN

Feb 21, 2025
pulisher
Feb 21, 2025

Are Wall Street Analysts Bullish On Revvity Stock? - Barchart

Feb 21, 2025
pulisher
Feb 20, 2025

Massachusetts Court Grants Permanent Injunction To Revvity Against Cloud Software Over Spotfire - Nasdaq

Feb 20, 2025
pulisher
Feb 20, 2025

Revvity Wins Permanent Injunction Enforcing Agreements With Cloud Software Group - Marketscreener.com

Feb 20, 2025
pulisher
Feb 20, 2025

Revvity Wins Permanent Injunction Against Cloud Software Group -February 20, 2025 at 01:06 pm EST - Marketscreener.com

Feb 20, 2025
pulisher
Feb 20, 2025

Revvity Wins Permanent Injunction Enforcing Agreements with Cloud Software Group - Business Wire

Feb 20, 2025
pulisher
Feb 20, 2025

Revvity to Present at Upcoming Investor Conferences - Business Wire

Feb 20, 2025
pulisher
Feb 20, 2025

Court Ruling Locks In Revvity's Exclusive Control of Critical Spotfire PlatformWhat This Means for Research Markets - Stock Titan

Feb 20, 2025
pulisher
Feb 19, 2025

How To Trade (RVTY) - Stock Traders Daily

Feb 19, 2025
diagnostics_research DGX
$169.20
price up icon 1.12%
$141.41
price down icon 1.76%
diagnostics_research LH
$232.74
price up icon 1.18%
diagnostics_research WAT
$368.57
price up icon 1.77%
diagnostics_research MTD
$1,180.91
price up icon 0.32%
diagnostics_research IQV
$176.30
price down icon 0.61%
大文字化:     |  ボリューム (24 時間):